Share on social media
Share on facebook
Share on twitter
Share on linkedin
Share on email
Miltenyi Biotec strengthens its research capabilities for cell analysis and preclinical imaging by acquiring a MILabs’ premium Optical/CT imaging system
Utrecht and Bergisch Gladbach, September 9, 2020 Miltenyi Biotec B.V. & Co. KG, a …
MILabs announced the co-winners of the MILabs Image of the Year Award
September 4, 2020, Utrecht, The Netherlands Each year, at the occasion of the Annual Congress …
Bayer AS installs top-of-the-line MILabs VECTor PET/SPECT/CT to advance its targeted alpha therapy programs
August 27, 2020, Oslo-Norway and Utrecht-The Netherlands Bayer AS has installed a state-of-the-art MILabs VECTor …
Spotlight on Prof. Marion de Jong – Erasmus MC Rotterdam
Spotlight on Prof. Marion de Jong – Erasmus MC Rotterdam On the frontline of fighting …
The University of Southampton enters the field of Correlative In-Vivo Imaging by acquiring MILabs 3D/4D Optical/CT
May 12, 2020, Southampton, UK – Utrecht, the Netherlands The Faculty of Medicine, University of …
MILabs remotely installs from the Netherlands new E-Class PET/SPECT/CT at Osaka University of Pharmaceutical Sciences
Osaka, Japan and Utrecht, the Netherlands May 4th, 2020 In a world with COVID-19 travel …
University of Torino (UNITO) acquires an advanced MILabs molecular imaging system
The University of Torino (UNITO) acquires advanced MILabs molecular imaging system for the design of …
Truman VA acquires VECTor preclinical imaging system featuring exclusive multimodal synergy capabilities.
Columbia, Missouri, USA and Utrecht, the Netherlands April 9th, 2020 Harry S. Truman Memorial Veterans’ …
Cyprus-based EPOS-Iasis acquires MILabs innovative Optical/CT system
Aimed at achieving a paradigm shift in Oncology research by imaging and quantifying fluorescent signals …
MILabs enhances micro-CT for Coronavirus (COVID-19) research.
March 19, 2020 – Utrecht, the Netherlands Based on recent scientific research, diagnostic X-ray CT …
The Julius Wolf Institute at the Charité installs mission-critical MILabs microCT for in-vivo studies of musculoskeletal regeneration
25 February 2020 – Berlin-Germany and Utrecht, Netherlands, The Julius Wolff Institute for Biomechanics and …
MILabs realizes a breakthrough in preclinical oncology imaging by eliminating the positron range effect of 89Zr-immunoPET
February 15, 2020 – Utrecht, the Netherlands Researchers at MILabs B.V. have succeeded at imaging …
